Locally relevant use cases can maximize national support for genomic sequencing in low- and middle-income countries.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Kanteh, A. et al. Lancet Glob. Health 10, e1240–e1241 (2022).
Ferdinand, A. S. et al. Genome Med. 13, 121 (2021).
Pronyk, P. M. et al. Cell Genom. 3, 100443 (2023).
Khoo, Y. K. et al. Cell Genom. 5, 100781 (2025).
Inzaule, S. C., Tessema, S. K., Kebede, Y., Ogwell Ouma, A. E. & Nkengasong, J. N. Lancet Infect. Dis. 21, e281–e289 (2021).
Golumbeanu, M., Edi, C. A. V., Hetzel, M. W., Koepfli, C. & Nsanzabana, C. Am. J. Trop. Med. Hyg. 112, 35–47 (2023).
Lyimo, B. M. et al. Front. Cell. Infect. Microbiol. 12, 757844 (2022).
Girgis, S. T. et al. Nat. Microbiol. 8, 2365–2377 (2023).
Hall, M. B. et al. Lancet Microbe 4, e84–e92 (2023).
WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis — Rapid Diagnostics for Tuberculosis Detection (World Health Organization, 2024).
Miyahara, R. et al. Emerg. Infect. Dis. 29, 477–483 (2023).
Kigen, C. et al. Microb. Genom. 9, mgen001098 (2023).
Mukhwana, A., Shorinola, O., Ndlovu, D.-F. & Osaso, J. Nature Index https://www.nature.com/nature-index/news/slow-difficult-expensive-how-lab-supplies-market-crippling-african-science (2024).
Liu, B., Huang, C., Wu, J., Yi, T. & Yuan, Z. J. Biosaf. Biosecur. 6, 27–33 (2024).
Marklewitz, M. et al. Front. Public Health 12, 1498094 (2025).
Acknowledgements
This article was supported by a grant (INV-053792) from the Gates Foundation. Two of the funder’s employees are co-authors on this manuscript and contributed as shown below. One US government author who contributed to this paper was required to withdraw from publication because of changes in policy within that organization.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G.L.A. has been a paid consultant for Clear Labs, Gingko Bioworks and Merck Research Laboratories and is an unpaid board member for a non-profit organization, the Theiagen Global Health Initiative. J.C. has received support from the Wellcome Trust, the Task Force for Global Health and ECCMID to support participation in scientific conferences. The other authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Armstrong, G.L., Harris, S.R., Pronyk, P.M. et al. The value of local use cases for expanding pathogen genomics in resource-limited settings. Nat. Health (2026). https://doi.org/10.1038/s44360-026-00084-3
Published:
Version of record:
DOI: https://doi.org/10.1038/s44360-026-00084-3